Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Validation of a de-immunization strategy for monoclonal antibodies using cynomolgus macaque as a surrogate for human.

Kovalova N, Boyles J, Wen Y, Witcher DR, Brown-Augsburger PL, Wroblewski VJ, Chlewicki LK.

Biopharm Drug Dispos. 2020 Feb 21. doi: 10.1002/bdd.2222. [Epub ahead of print]

PMID:
32080869
2.

Correlation between antidrug antibodies, pre-existing antidrug reactivity, and immunogenetics (MHC class II alleles) in cynomolgus macaque.

Kovalova N, Knierman MD, Brown-Augsburger PL, Wroblewski VJ, Chlewicki LK.

Immunogenetics. 2019 Nov;71(10):605-615. doi: 10.1007/s00251-019-01136-7. Epub 2019 Nov 27.

PMID:
31776588
3.

Disposition of Basal Insulin Peglispro Compared with 20-kDa Polyethylene Glycol in Rats Following a Single Intravenous or Subcutaneous Dose.

Knadler MP, Ellis BB, Brown-Augsburger PL, Murphy AT, Martin JA, Wroblewski VJ.

Drug Metab Dispos. 2015 Oct;43(10):1477-83. doi: 10.1124/dmd.115.064337. Epub 2015 Jul 14.

PMID:
26175543
4.
5.

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure.

Frolik CA, Black EC, Cain RL, Satterwhite JH, Brown-Augsburger PL, Sato M, Hock JM.

Bone. 2003 Sep;33(3):372-9.

PMID:
13678779

Supplemental Content

Loading ...
Support Center